nsc-172755 has been researched along with mefloquine in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 5 (71.43) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akogbeto, M; Chippaux, JP; Josse, R; Massougbodji, A; Sadeler, BC; Zohoun, T | 1 |
Aubouy, A; Bertin, G; Deloron, P; Fievet, N; Kinde-Gazard, D; Kiniffo, R; Kossou, H; Massougbodji, A; Sagbo, JC | 1 |
Bouraima, A; Briand, V; Choudat, I; Cot, M; Cottrell, G; Dechavanne, C; Fayomi, B; Garcia, A; Guerra, J; Le Port, A; Massougbodji, A; Migot-Nabias, F | 1 |
Bertin, G; Bonaventure, D; Briand, V; Carrieu, A; Cot, M; Deloron, P; Massougbodji, A | 1 |
Afangnihoun, A; Agossou, VK; Akakpo, J; Atadokpédé, F; Briand, V; Clément, MC; Cot, M; Denoeud-Ndam, L; Dossou-Gbété, L; Girard, PM; Komongui, DG; Zannou, DM | 1 |
Afangnihoun, A; Atadokpede, F; Cot, M; Denoeud-Ndam, L; Dossou-Gbete, L; Fourcade, C; Girard, PM; Komongui, DG; Ndam, NT; Porcher, R; Taron-Brocard, C; Zannou, DM | 1 |
Briand, V; Cot, M; Escolano, S; Journot, V; Massougbodji, A; Tubert-Bitter, P | 1 |
5 trial(s) available for nsc-172755 and mefloquine
Article | Year |
---|---|
Dramatically decreased therapeutic efficacy of chloroquine and sulfadoxine-pyrimethamine, but not mefloquine, in southern Benin.
Topics: Administration, Oral; Animals; Antigens, Protozoan; Antimalarials; Benin; Child, Preschool; Chloroquine; DNA, Protozoan; Drug Combinations; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Merozoite Surface Protein 1; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Treatment Failure; Treatment Outcome | 2007 |
Prevention of malaria during pregnancy: assessing the effect of the distribution of IPTp through the national policy in Benin.
Topics: Adult; Antimalarials; Benin; Chloroquine; Drug Combinations; Female; Health Policy; HIV Infections; Humans; Infant, Low Birth Weight; Infant, Newborn; Malaria; Maternal Age; Mefloquine; Multivariate Analysis; Placenta; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Risk Factors; Sulfadoxine; Young Adult | 2011 |
Tolerability of mefloquine intermittent preventive treatment for malaria in HIV-infected pregnant women in Benin.
Topics: Adult; Antimalarials; Benin; Chemoprevention; Cohort Studies; Drug-Related Side Effects and Adverse Reactions; Female; HIV Infections; Humans; Malaria; Mefloquine; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies | 2012 |
Cotrimoxazole prophylaxis versus mefloquine intermittent preventive treatment to prevent malaria in HIV-infected pregnant women: two randomized controlled trials.
Topics: Adult; Antimalarials; Benin; Chemoprevention; Dizziness; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; HIV Infections; Humans; Infant; Infant, Newborn; Malaria; Mefloquine; Parasitemia; Pregnancy; Pregnancy Complications, Parasitic; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Young Adult | 2014 |
Mefloquine Versus Sulfadoxine-Pyrimethamine for Intermittent Preventive Treatment in Pregnancy: A Joint Analysis on Efficacy and Tolerability.
Topics: Anemia; Antimalarials; Benin; Drug Combinations; Female; Humans; Infant, Low Birth Weight; Malaria; Mefloquine; Placenta; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Stillbirth; Sulfadoxine; Treatment Outcome | 2015 |
2 other study(ies) available for nsc-172755 and mefloquine
Article | Year |
---|---|
[Development of chemoresistance of Plasmodium falciparum to chloroquine and mefloquine in Benin between 1980 and 1989].
Topics: Animals; Benin; Child; Chloroquine; Drug Resistance; Humans; Mefloquine; Plasmodium falciparum | 1990 |
Molecular markers of resistance to sulphadoxine-pyrimethamine during intermittent preventive treatment of pregnant women in Benin.
Topics: Adult; Antimalarials; Benin; Biomarkers; Chemoprevention; Clinical Trials as Topic; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Female; Gene Dosage; Genotype; Humans; Malaria, Falciparum; Mefloquine; Multidrug Resistance-Associated Proteins; Mutation, Missense; Plasmodium falciparum; Pregnancy; Pregnancy Complications; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2011 |